Authorized by the FDA for COVID-19 Treatment
-
Emergency Use of Gilead's Remdesivir Authorized by the FDA for COVID-19 Treatment
The USFDA or US Food & Drug Administration has authorized remdesivir for emergency use last Friday. The early phase of clinical trials showed that remdesivir, an anti-viral drug, has some preliminary promising results for treating COVID-19 patients.
Latest Research Articles